Search

Your search keyword '"Biomarkers, Tumor"' showing total 183,277 results

Search Constraints

Start Over You searched for: Descriptor "Biomarkers, Tumor" Remove constraint Descriptor: "Biomarkers, Tumor"
183,277 results on '"Biomarkers, Tumor"'

Search Results

1. 异常凝血酶原对肝细胞癌的诊断效能及其与肿瘤临床特征的 相关性分析.

2. ATOX1通过JAK2/STAT3通路促进肝癌细胞 生物学行为的机制探讨.

3. A call for objectivity: Radiologists’ proposed wishlist for response evaluation in solid tumors (RECIST 1.1)

4. Research advances in the association of epithelial cell adhesion molecule with lung cancer, breast cancer, and some digestive system tumors

5. The molecular signature and prognosis of glioma with preoperative intratumoral hemorrhage: a retrospective cohort analysis

6. The application of 18F-FDG PET/CT with tumor markers NSE and ProGRP in the diagnosis and treatment of small cell lung cancer

7. Clinicopathological Features and Molecular Signatures of Lateral Neck Lymph Node Metastasis in Papillary Thyroid Microcarcinoma

8. Study on the Mechanisms of Multiple Myeloma Cells Promoting M2 Macrophage Polarization through PI3K/AKT Signaling Pathway

9. Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria.

10. Prediction Value of B-ultrasound with Tumor Markers for Malignant Transformation of Mucinous Ovarian Tumors

12. The molecular signature and prognosis of glioma with preoperative intratumoral hemorrhage: a retrospective cohort analysis

14. Identification of novel biomarkers with potential for diagnosis and prognosis of gastric cancer: a Bioinformatics Approach

15. CANCER-ASSOCIATED STROKE IN A PATIENT WITH TESTICULAR CANCER – CASE REPORT.

16. Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification.

17. Entzündung im Blut – was steckt dahinter?

18. Exploring the Gut Microbiome in Cancer : From Biomarkers to Personalized Therapies

20. 宫颈癌新辅助化疗的疗效评估.

21. Influence of buccal acupuncture on analgesic effect, immune indicators, and expression of Survivin and Livin proteins in patients with advanced-stage primary liver cancer.

22. Use of circulating tumour DNA in nasopharyngeal carcinoma to detect minimal residual disease

23. Refining the Optimal CAF Cluster Marker for Predicting TME-Dependent Survival Expectancy and Treatment Benefits in NSCLC Patients

25. A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer

26. Quantification of the lung cancer tumor marker CYFRA 21-1 using protein precipitation, immunoaffinity bottom-up LC-MS/MS

27. Predictive and Prognostic Biomarkers and Tumor Antigens for Targeted Therapy in Urothelial Carcinoma

28. Artificial intelligence-based personalized survival prediction using clinical and radiomics features in patients with advanced non-small cell lung cancer.

29. Uncovering the predictive and immunomodulatory potential of transient receptor potential melastatin family-related CCNE1 in pan-cancer.

30. Current biological implications and clinical relevance of metastatic circulating tumor cells.

31. Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial.

32. Hepatocellular Carcinoma Immune Microenvironment Analysis: A Comprehensive Assessment with Computational and Classical Pathology.

33. Clinicopathologic feature and treatment progress of high-grade ovarian neuroendocrine tumors.

34. Role of ENO1 and its targeted therapy in tumors.

35. Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial.

36. Regulatory T cells in immune checkpoint blockade antitumor therapy.

37. Lung cancer exosomal Gal3BP promotes osteoclastogenesis with potential connotation in osteolytic metastasis.

38. A novel hypoxia- and lactate metabolism-related prognostic signature to characterize the immune landscape and predict immunotherapy response in osteosarcoma.

39. Association of artificial intelligence-based immunoscore with the efficacy of chemoimmunotherapy in patients with advanced non-squamous non-small cell lung cancer: a multicentre retrospective study.

40. Deciphering the role of host-gut microbiota crosstalk via diverse sources of extracellular vesicles in colorectal cancer.

41. Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study.

42. [Detection of circulating tumor cells in women with early breast cancer].

43. Bladder cancer immune-related markers: diagnosis, surveillance, and prognosis.

44. MRTO4 acts as an independent prognostic and immunological biomarker and is correlated with tumor microenvironment in hepatocellular carcinoma.

45. Knockdown of ENO1 promotes autophagy dependent-ferroptosis and suppresses glycolysis in breast cancer cells via the regulation of CST1.

46. Prostate cancer theragnostics biomarkers: An update.

47. A prognostic nomogram for T3N0M0 esophageal squamous cell carcinoma patients undergoing radical surgery based on computed tomography radiomics and inflammatory nutritional biomarkers.

48. Highly Multiplexed Tissue Imaging in Precision Oncology and Translational Cancer Research.

49. Combination Diagnostics: Adding Blood-Based ctDNA Screening to Low-Dose CT Imaging for Early Detection of Lung Cancer.

50. Inflammatory Burden Index Is an Independent Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment.

Catalog

Books, media, physical & digital resources